Azathioprine in Recurrent Implantation Failure

In Vitro Fertilization Clinical Trial

Official title:

Azathioprine in Recurrent Implantation Failure

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03498703
• Other study ID #: FW000372
• Status: Completed
• Phase: Phase 2
• Start date: April 25, 2018
• Est. completion date: July 1, 2019

Study information

• Verified date: July 2019
• Source: Ain Shams University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Azathioprine increase pregnancy rate in patients with recurrent implantation failure

Recruitment information / eligibility

• Status: Completed
• Enrollment: 64
• Est. completion date: July 1, 2019
• Est. primary completion date: July 1, 2019
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 20 Years to 39 Years

Eligibility

Inclusion Criteria:

• age: 20-39

• previous 3 or more failed ivf

Exclusion Criteria:

• intrauterine anomalies

• chronic systemic illness

• chronic pelvic conditions

• sensitivety to azathioprine

Related Conditions & MeSH terms

• In Vitro Fertilization
• Intracytoplsmic Sperm Injection
• Recurrent Implantation Failure

Intervention

Drug:
• Azathioprine Pill
Azathioprine increase pregnancy rate in cases with recurrent implantaion failure
• Placebo Oral Tablet
Placebo tablets

Locations

Country	Name	City	State
Egypt	Ain Shams University, Maternity Hospital	Cairo
Egypt	Capital Birth Center	Cairo

Sponsors (2)

Lead Sponsor	Collaborator
Ain Shams University	Capital Birth Center

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Clinical pregnancy rate		2 weeks
Secondary	Side effects		2 weeks